Microparticulated and nanoparticulated zirconium oxide added to calcium silicate cement: Evaluation of physicochemical and biological properties

Journal of Biomedical Materials Research - Part A

Volumn 102, Issue 12, 2014, Pages 4336-4345

  Silva, Guilherme F ^a   Bosso, Roberta ^a   Ferino, Rafael V ^a   Tanomaru Filho, Mário ^a   Bernardi, Maria I B ^b   Guerreiro Tanomaru, Juliane M ^a   Cerri, Paulo S ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Biocompatibility; Calcium silicate cement; Physicochemical properties; Radiopacifying agents

Indexed keywords

ALKALINITY; BIOCOMPATIBILITY; CALCIUM; CEMENTS; COMPRESSIVE STRENGTH; IONS; OXIDES; SILICATES; STRENGTH OF MATERIALS; TUBES (COMPONENTS); ZIRCONIA; ZIRCONIUM; ZIRCONIUM ALLOYS;

BIOLOGICAL PROPERTIES; BIOLOGICAL RESPONSE; CALCIUM SILICATE CEMENT; COMPRESSION STRENGTH; IMMUNOHISTOCHEMISTRY; IMPLANTED MATERIALS; PHYSICOCHEMICAL PROPERTY; POSITIVE STRUCTURES;

CALCIUM SILICATE;

BISMUTH; BISMUTH OXIDE; CALCIUM ION; CALCIUM SILICATE; INTERLEUKIN 6; POLYETHYLENE; UNCLASSIFIED DRUG; ZIRCONIUM OXIDE; BONE CEMENT; CALCIUM DERIVATIVE; NANOPARTICLE; SILICATE; ZIRCONIUM;

ALKALINITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BIOLOGICAL ACTIVITY; CALCIUM TRANSPORT; COMPARATIVE STUDY; COMPRESSIVE STRENGTH; CONTROLLED STUDY; GIANT CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; MACROPHAGE; NONHUMAN; PH; PHYSICAL CHEMISTRY; RAT; ANIMAL; CHEMICALLY INDUCED; CHEMISTRY; EVALUATION STUDY; INFLAMMATION; MATERIALS TESTING; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BONE CEMENTS; CALCIUM COMPOUNDS; INFLAMMATION; INTERLEUKIN-6; MATERIALS TESTING; NANOPARTICLES; RATS; RATS, SPRAGUE-DAWLEY; SILICATES; ZIRCONIUM;

EID: 84911806291     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.35099     Document Type: Article

References (40)

1. Lee SJ, Monsef M, Torabinejad M. Sealing ability of mineral trioxide aggregate for repair of lateral root perforations. J Endod 1993; 19:541-544.
2. Silva GF, Guerreiro-Tanomaru JM, Sasso-Cerri E, Tanomaru-Filho M, Cerri PS. Histological and histomorphometrical evaluation of furcation perforations filled with MTA, CPM and ZOE. Int Endod J 2011;44:100-110.
3. Wucherpfennig AL, Green DB. Mineral trioxide vs. Portland cement: Two biocompatible filling materials. J Endod 1999;25: 308; Abstract No. 40.
4. Wynn-Jones G, Shelton RM, Hofmann MP. Development of Portland cement for orthopedic applications, establishing injectability and decreasing setting times. J Biomed Mater Res Part B 2012: 100B:2213-2221.
5. Bortoluzzi EA, Guerreiro-Tanomaru JM, Tanomaru-Filho M, Duarte MAH. Radiographic effect of different radiopacifiers on a potential retrograde filling material. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009;108:628-632.
6. Duarte MAH, El Kadre GDO, Vivan RR, Guerreiro-Tanomaru JM, Tanomaru-Filho M, de Moraes IG. Radiopacity of Portland cement associated with different radiopacifying agents. J Endod 2009;35: 737-740.
7. Duarte MAH, Minotti PG, Rodrigues CT, Ordinola-Zapata R, Bramante CM, Tanomaru-Filho M, Vivan RR, de Moraes IG, de Andrade FB. Effect of different radiopacifying agents on the physicochemical properties of white Portland cement and white mineral trioxide aggregate. J Endod 2012;38:394-397.
8. Coomaraswamy KS, Lumley PJ, Hofmann MP. Effect of bismuth oxide radioopacifier content on the material properties of an endodontic Portland cement-based (MTA-like) system. J Endod 2007;33:295-298.
9. Camilleri J. Hydration mechanisms of mineral trioxide aggregate. Int Endod J 2007;40:462-470.
10. Tanomaru-Filho M, Morales V, Silva GF, Bosso R, Reis JMSN, Duarte MAH, Guerreiro-Tanomaru JM. Compressive strength and setting time of MTA and Portland cement associated with different radiopacifying agents. ISRN Dent 2012;2012:898051.
11. Camilleri J. The physical properties of accelerated Portland cement for endodontic use. Int Endod J 2008;41:151-157.
12. Camilleri J, Montesin FE, Papaioannou S, McDonald F, Pitt Ford TR. Biocompatibility of two commercial forms of mineral trioxide aggregate. Int Endod J 2004;37:699-704.
13. Min KS, Kim HI, Park HJ, Pi SH, Hong CU, Kim EC. Human pulp cells response to Portland cement in vitro. J Endod 2007;33:163-166.
14. Cutajar A, Mallia B, Abela S, Camilleri J. Replacement of radiopacifier in mineral trioxide aggregate; characterization and determination of physical properties. Dent Mater 2011;27:879-891.
15. Camilleri J, Cuttajar A, Mallia B. Hydration characteristics of zirconium oxide replaced Portland cement for use as a root-end filling material. Dent Mater 2011;27:845-854.
16. Komabayashi T, Spangberg L. Comparative analysis of the particle size and shape of commercially available mineral trioxide aggregates and Portland cement: A study with a flow particle image analyzer. J Endod 2008;34:94-98.
17. Saghiri MA, Asgar K, Lofti M, Garcia-Godoy F. Nanomodification of mineral trioxide aggregate for enhanced physiochemical properties. Int Endod J 2012;45:979-988.
18. Liu X, Huang A, Ding C, Chu PK. Bioactivity and cytocompatibility of zirconia (ZrO2) films fabricated by cathodic arc deposition. Biomaterials 2006;27:3904-3911.
19. Saldaña L, Méndez-Vilas A, Jiang L, Multigner M, González- Carrasco JL, Pérez-Prado MD, González-Martin ML, Munuera L, Vilaboa N. In vitro biocompatibility of an ultrafine grained zirconium. Biomaterials 2007;28:4343-4354.
20. Vivan RR, Ordinola-Zapata R, Zeferino MA, Bramante CM, Bernardineli N, Garcia RB, Duarte MAH, Tanomaru-Filho M, de Moares IG. Evaluation of the physical and chemical properties of two commercial and three experimental root-end filling materials. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010;110:250-256.
21. International Organization for Standardization. ISO 6876: Dental Root Sealing Materials. Geneva: The Organization; 2001.
22. American National Standard. American Dental Association Specification n 57 for Endodontic Filling Materials. Chicago: American Dental Association (ADA); 1984.
23. American Society for Testing and Materials. Standard Test Method for Time and Setting of Hydraulic-Cement Paste by Gillmore Needles, ASTM C266-03. Philadelphia: American Society for Testing and Materials (ASTM); 2000.
24. Bortoluzzi EA, Broon NJ, Bramante CM, Felippe WT, Tanomaru- Filho M, Esberard RM. The influence of calcium chloride on the setting time, solubility, disintegration, and pH of mineral trioxide aggregate and white Portland cement with a radiopacifier. J Endod 2009;35:550-544.
25. International Organization for Standardization. ISO 9917-1: Dentistry - Water-Based Cements - Part 1: Powder/Liquid Acid- Base Cements. Geneva: The Organization; 2003.
26. Viola NV, Guerreiro-Tanomaru JM, Silva GF, Sasso-Cerri E, Tanomaru-Filho M, Cerri PS. Morphological and morphometric analysis of the biocompatibility of an experimental MTA sealer. J Biomed Mater Res Part B 2012;100:1773-1781.
27. Longhini R, de Oliveira PA, Faloni APS, Sasso-Cerri E, Cerri PS. Increased apoptosis in osteoclasts and decreased RANKL immunoexpression in periodontium of cimetidine-treated rats. J Anat 2013;222:239-247.
28. Gomes-Filho JE, Watanabe S, Bernabe PFE, Costa MTM. A mineral trioxide aggregate sealer stimulated mineralization. J Endod 2009;35:256-260.
29. Islam I, Chng HK, Yap AUJ. Comparison of the physical and mechanical properties of MTA and Portland cement. J Endod 2006;32:193-197.
30. Shahi S, Rahimi S, Yavari HR, Mokthari H, Roshangar L, Abasi MM, Sattari S, Abdolrahimi M. Effect of mineral trioxide aggregates and Portland cements on inflammatory cells. J Endod 2010; 36:899-903.
31. Vosoughhosseini S, Lotfi M, Shahi S, Baloo H, Mesgariabbasi M, Ali Saghiri M, Zand V, Rahimi S, Ranjkesh B. Influence of white versus gray mineral trioxide aggregate on inflammatory cells. J Endod 2008;34:715-717.
32. Schroder AK, Ohe M, Kolling U, Altstaedt J, Uciechowski P, Fleischer D, Dalhoff K, Ju X, Zenke M, Heussen N, Rink L. Polymorphonuclear leucocytes selectively produce anti-inflammatory interleukin-1 receptor antagonist and chemokines, but fail to produce pro-inflammatory mediators. Immunology 2006;119:317-327.
33. Hrabak A, Bajor T, Csuka I. The effect of various inflammatory agents on the phagocytosis and cytokine profile of mouse and rat macrophages. Inflam Res 2008;57:75-83.
34. Nibali L, Fedele S, D'Aiuto F, Donos N. Interleukin-6 in oral diseases: A review. Oral Dis 2012;18:236-246.
35. Phan TC, Xu J, Zheng MH. Interaction between osteoblast and osteoclast: Impact in bone disease. Histol Histopathol 2004;19:1325-1344.
36. Wisithphrom K, Windsor LJ. The effects of tumor necrosis factoralpha, interleukin-1 beta, interleukin-6, and transforming growth factor-beta 1 on pulp fibroblast mediated collagen degradation. J Endod 2006;32:853-861.
37. Katchburian E, Antoniazzi MM, Jared C, Faria FP, Souza Santos H, Freymüller E. Mineralized dermal layer of the Brazilian tree-frog Corythomantis greeningi. J Morphol 2001;248:56-63.
38. Seux D, Couble ML, Hartmann DJ, Gauthier JP, Magloire H. Odontoblast-like cytodifferentiation of human dental pulp cells in vitro in the presence of calcium hydroxide cement. Arch Oral Biol 1991;36:117-128.
39. Sarkar NK, Caicedo R, Ritwik P, Moiseyeva R, Kawashima I. Physicochemical basis of the biologic properties of mineral trioxide aggregate. J Endod 2005;31:97-100.
40. Sodek J, Ganss B, McKee MD. Osteopontin. Crit Rev Oral Biol Med 2000;11:279-303.